Evidence map›Paper›PMID 40286180›Full record

ReviewMolecules (Basel, Switzerland)2025

Blue Exciplexes in Organic Light-Emitting Diodes: Opportunities and Challenges.

Duxu Yan, Mengmeng Zhang, Jintao Wang, Xiaoqing Jing, Jun Sun, Yongan Zhang, Liping Yang, Ren Sheng, Ping Chen

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Duxu YanInstitute of Physics and Electronic Information, Yantai University, Yantai 264005, China.
Mengmeng ZhangInstitute of Physics and Electronic Information, Yantai University, Yantai 264005, China.
Jintao WangSchool of Information Engineering, Yantai Institute of Technology, Yantai 264005, China.
Xiaoqing JingInstitute of Physics and Electronic Information, Yantai University, Yantai 264005, China.
Jun SunInstitute of Physics and Electronic Information, Yantai University, Yantai 264005, China.
Yongan ZhangInstitute of Physics and Electronic Information, Yantai University, Yantai 264005, China.
Liping YangSchool of Information Engineering, Yantai Institute of Technology, Yantai 264005, China.
Ren ShengInstitute of Physics and Electronic Information, Yantai University, Yantai 264005, China.
Ping ChenInstitute of Physics and Electronic Information, Yantai University, Yantai 264005, China.

Funding

National Natural Science Foundation of China 62474154,62205281
6 · The paper itself

Abstract

Blue exciplexes, a critical innovative component in organic light-emitting diodes (OLEDs) technology, exhibit substantial potential for enhancing device efficiency, reducing driving voltage, and simplifying structural designs. This article reviews the pivotal role of blue exciplexes in OLEDs, analyzing their unique advantages and challenges as emitters and host materials. Through optimized molecular design, blue exciplexes achieve high color purity and emission efficiency, surpassing conventional fluorescent materials. Additionally, their wide energy bands and high triplet energy provide opportunities to improve the performance of sky-blue, deep-blue, and white OLEDs. However, limitations in deep-blue efficiency, material degradation due to high-energy excitons, and spectral red-shift pose significant challenges to their development. This review offers a comprehensive perspective and research reference on the photophysical mechanisms of blue exciplexes and their applications in display and lighting fields.

Indexed as

blue emissionblue exciplexefficiencyhost materialsOLEDTADF

Identifiers

PMID40286180
PMCPMC11990462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.